John B. Konefal, MD
"I was impressed with the rapidly evolving technology and potential of radiation in curing, extending the lives, and improving the quality of life of cancer patients."
- Dr. Konefal
Hamilton, New York
B. A. (Combined Majors: Physics, Chemistry, Math)
University of Vermont College of Medicine
M.D. (Major - Internal Medicine)
University of Kentucky Medical Center
Mallinckrodt Institute of Radiology
Washington University Medical Center
St. Louis, Missouri (Radiation Oncology)
Southeast Radiation Oncology Group, PA
“Malignant Melanoma: Analysis of Dose Fractionation in Radiation Therapy.” Radiology. September 1987; Vol. 164:607- 610.
“Radiation Therapy in the Treatment of Chemodectomas.” Laryngoscope. November 1987; Vol. 97. No.11:1331-1335.
Analysis of Dose Fractionation in the Palliation of Metastases from Malignant Melanoma.” Cancer. January 15, 1988; Vol. 61,
“Radiation Therapy in Chemodectoma Treatment (letter to the editor).” Laryngoscope. April 1988; Vol. 98, No. 4:465-466.
“The Effects of Altered Fractionation Schedules on the Survival of Human Cell Lines Differing in Their Proliferative Activity and Repair Capacity.” International Journal of Radiation Oncology, Biology and Physics. 1990 Vol. 17, pp. 1007 – 1013.
“Thermoradiotherapy of Malignant Melanoma.” International Journal of Hyperthermia. 1988, Vol. 4, No. 4:373 – 381.
“Endocavitary Radiation for Rectal Carcinoma: Results with and without External Beam.” Endocurietherapy/Hyperthermia Oncology. 1989; 5:195-200.
+ Selected Meeting Presentations
“Radiation Therapy of Malignant Melanoma: Analysis of Dose Fractionation.” The Radiological Society of North America, 73rd Scientific Assembly and Annual Meeting. December 3, 1987
“Endocavitary Radiation for Early Rectal Carcinomas: The Experience at Washington University.” American Society Therapeutic Radiology and Oncology, 29th Annual Meeting. October 23, 1987
“The Effects of Altered Fractionation Schedules on the Survival of Human Cell Lines Differing in their Proliferative Activity and Repair Capacity.” American Society Therapeutic Radiology and Oncology, 30th Annual Meeting. October 10, 1988
Comments are closed.
- What You Need to Know About Stereotactic Radiosurgery and Its Impact on Brain Tumor Treatment
- Meet Derek McHaffie, MD, November 2019 Provider of the Month
- SERO Sponsors 5K to Raise Scholarship Funds
- Dr. Aaron Wild Joins Southeast Radiation Oncology Group
- How Frequently Do You Need Radiation Therapy?